Risk factors for arterial catheter failure and complications during critical care hospitalisation: a secondary analysis of a multisite, randomised trial.

"Declarations Ethics approval and consent to participateEthical approval was obtained from Griffith University (Ref No: 2021/834). Written informed consent was obtained for each participant in the parent RCT. Consent for publicationNot applicable. Competing interestsJAS, ERY, RSW, MM, MM, JG, KRC, AR, HY have no conflicts to disclose. NM: Griffith University and The University of Queensland have received on her behalf investigator-initiated grants from 3 M, Cardinal Health and Eloquest, and consultancy payments from 3 M and Becton Dickinson for expert advice/ educational sessions. EL: EL’s affiliate (University of Queensland) has received, on her behalf: an investigator-initiated research grant from Eloquest Healthcare, unrelated to this work; EL was also awarded scholarship for conference attendance, by Angiodynamics, unrelated to this work. AC: ACs employer, on my behalf, has received investigator-initiated grants from 3 M, Cardinal Health and Eloquest Healthcare. These grants are unrelated to this work. EA: EA’s employer (Southwestern Sydney Local Health District) has received investigator-initiated research grants from Becton Dickinson-Bard and Eloquest Healthcare. EA has also received consultancy payments for educational lectures/expert advice from 3 M and ITL medical. CMR: CMR’s employer’s (Griffith University or The University of Queensland) received on her behalf unrestricted research or education grants from 3 M, BD-Bard, Cardinal Health, Eloquest and consultancy payments from 3 M, BD-Bard and ITL Healthcare. Competing interests JAS, ERY, RSW, MM, MM, JG, KRC, AR, HY have no conflicts to disclose. NM: Griffith University and The University of Queensland have received on her behalf investigator-initiated grants from 3 M, Cardinal Health and Eloquest, and consultancy payments from 3 M and Becton Dickinson for expert advice/ educational sessions. EL: EL’s affiliate (University of Queensland) has received, on her behalf: an investigator-initiated research grant from Eloquest Healthcare, unrelated to this work; EL was also awarded scholarship for conference attendance, by Angiodynamics, unrelated to this work. AC: ACs employer, on my behalf, has received investigator-initiated grants from 3 M, Cardinal Health and Eloquest Healthcare. These grants are unrelated to this work. EA: EA’s employer (Southwestern Sydney Local Health District) has received investigator-initiated research grants from Becton Dickinson-Bard and Eloquest Healthcare. EA has also received consultancy payments for educational lectures/expert advice from 3 M and ITL medical. CMR: CMR’s employer’s (Griffith University or The University of Queensland) received on her behalf unrestricted research or education grants from 3 M, BD-Bard, Cardinal Health, Eloquest and consultancy payments from 3 M, BD-Bard and ITL Healthcare."

"Funding This study was not funded."

"Trial registration Australian New Zealand Clinical Trial Registry (ACTRN 12610000505000); date registered: 18 June 2010."